Performance of multiplex bead based assay for detection of neutralizing antibodies in SARS CoV-2 infected and vaccinated individuals
VirusDisease
; 34(1):115, 2023.
Article
in English
| EMBASE | ID: covidwho-2315072
ABSTRACT
Background:
After the pandemic of SARS COV2 it is evolving and causing a threat and concern worldwide. Studies on variants are crucial in understanding the change in virulence and transmissibility of the virus and further vaccine efficacy. Plaque reduction neutralization test (PRNT) is the gold standard to detect neutralizing antibodies. Consequently, it is essential to explore other neutralization platforms which give promising results with quick turnaround time and safety compared to live neutralization assay. Objective(s) To compare and evaluate the neutralizing antibody responses of a multiplex bead-based assay (MBA), using the SARSCoV- 2 Variants Neutralizing Antibody Human 5-Plex ProcartaPlexTM Panel, with PRNT and further evaluate it to estimate the neutralizing responses in infected and vaccinated individuals. Material(s) and Method(s) Confirmed RT PCR covid positive and serum samples from vaccinated individuals (Covaxin and Covishield) were assesssed for the presence of neutralizing antibodies using Multiplex bead assay Human 5-Plex ProcartaPlexTM kit. Result(s) The sensitivity and specificity of MBA was less as compared to PRNT. In our study, we observed that qualitative assay was more comparable than quantitative assay. Conclusion(s) This study demonstrated the utility of MBA for simultaneous measurement of neutralizing antibodies against multiple SARS-CoV-2 strains in serum. The qualitative assay performance was imparted excellent with high sensitivity and specificity but variation in quantitative titres was observed compared to live neutralization assay titres.
adult; antibody response; conference abstract; controlled study; coronavirus disease 2019; drug combination; drug therapy; human; human tissue; nonhuman; plaque reduction neutralization test; quantitative assay; sensitivity and specificity; Severe acute respiratory syndrome coronavirus 2; turnaround time; covaxin; neutralizing antibody; vaxzevria
Full text:
Available
Collection:
Databases of international organizations
Database:
EMBASE
Topics:
Vaccines
Language:
English
Journal:
VirusDisease
Year:
2023
Document Type:
Article
Similar
MEDLINE
...
LILACS
LIS